C
Chunyu Yisheng
Chinese smartphone application that lets users remotely consult with physicians to diagnose their ailments
About Chunyu Yisheng
In 2011, Rui Zhang founded Chunyu Yisheng, a company that would become a trailblazer in China's mobile health industry. The vision was simple yet ambitious: to provide accessible healthcare through an online platform where users could consult with doctors remotely. This innovation was timely, addressing the growing demand for healthcare services in a country with a vast population and limited medical resources.
Chunyu Yisheng quickly gained traction, becoming the largest telemedicine platform in China. The platform's success was fueled by its ability to connect patients with healthcare professionals efficiently, offering consultations that were both convenient and reliable. This model not only improved access to healthcare but also set a new standard for medical consultations in the digital age.
Over the years, Chunyu Yisheng attracted significant investment, raising approximately $244 million in funding. This financial backing was crucial in scaling the platform and enhancing its technological capabilities. The company's growth mirrored the broader trend of digital transformation in healthcare, positioning Chunyu Yisheng as a leader in the field.
Despite its achievements, Chunyu Yisheng faced challenges typical of the telemedicine industry, including regulatory hurdles and the need to maintain high standards of medical care. However, the company's commitment to innovation and quality helped it navigate these obstacles, ensuring its continued relevance and impact.
Today, Chunyu Yisheng stands as a testament to the power of technology in revolutionizing healthcare, offering a glimpse into the future of medical services in China and beyond.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2011
- Headquarters
- Dongcheng District, China
- Employees
- 83
- Open positions
- None listed
- Dealroom signal
- 60.1/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Pharmacy, Telemedicine, Tech for Patients, Rumoured $1B, Hard Tech
- Technology
- Mobile app
- Business model
- SaaS
- Client focus
- b2c
- Investment activity
- 1 company, latest Oct 2014
- Capital deployed
- $491K
- Preferred round
- ANGEL
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Dec 2025 | $37M | $47M | Guorui Life | ↗ |
| LATE VCOther financing | Mar 2020 | $0 | — | Sogou | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Chunyu Yisheng is 280K monthly website visits, up 75% over the last three months. Chunyu Yisheng's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
BlueRun Ventures
Other known investors1 additional known investor
- GLGuorui Life
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chunyu Yisheng on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chunyu Yisheng’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











